Navigation Links
Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
Date:9/22/2009

s showed a low TLR rate of 4.6 percent, a per protocol SAT and late thrombosis rate of 0.9 percent, and a MACE rate of 8.9 percent.

"The MACE rate is only 1.2 percent higher than the full cohort of the study and was mainly driven by mortality," said de Winter. "We expect a higher mortality rate in diabetic patients due to other comorbidities."

e-HEALING is a multi-center, worldwide (outside the United States) prospective clinical study conducted in 31 countries at 144 clinical centers. In addition to 25 percent of patients having diabetes mellitus, 42.4 percent of the patients had unstable angina and 11 percent had pre-procedure thrombus. For the lesions treated, 49.3 percent were type B2 or C. The study protocol recommends that patients receive one month of clopidogrel treatment after the index procedure. The primary endpoint of the study is target vessel failure at 12 months. The advanced electronic data capture via the internet with built in consistency checks for data monitoring was conducted by KIKA Clinical Solutions, a leading provider of advanced EDC solutions for clinical trials. Cardialysis, an independent Contract Research Organization (CRO), ensured quality, consistency and completeness of the data through comprehensive data management and monitoring.

Sigmund Silber, M.D., F.A.C.C., F.E.S.C., a professor of medicine with the Cardiology Practice and Hospital, Munich, and co-principle investigator, said, "Physicians rely on evidence-based recommendations for coronary interventions, and results from multicenter studies are more meaningful than those from a single center. The results from the large, multicenter e-HEALING study demonstrate the safety and efficacy of the Genous Bio-engineered R stent in a broad patient population - including remarkable outcomes for diabetic patients. This patient population shows a similar clinical outcome at 12-month follow-up compared to the total e-HEALING cohort,
'/>"/>

SOURCE OrbusNeich
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cadient Group Selected as Finalist in Medical Marketing & Media Awards
2. Prix Galien USA Announces 2009 Final Candidates
3. Quest Diagnostics Announces Final Tender Offer Results
4. Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
5. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
6. Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award
7. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer
8. Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006
9. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
10. University of Maryland Announces Finalists for $75K Business Plan Competition
11. Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Boston Scientific Corporation (NYSE: BSX ) today ... billion aggregate principal amount of its senior notes under ... consists of $850 million of 4.50 percent notes due ... January 2020 and $300 million of 7.375 percent notes ... the net proceeds for general corporate purposes, including prepaying ...
(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) ... to serve on its board of directors. ... over 35 years of experience in corporate management, ... Nektar extensive industry perspective at an important time ... President and CEO of Nektar and member of ...
(Date:12/14/2009)... company, has completed the delivery of Brookfield Engineering’s Powder Flow ... plastic enclosure with a smaller footprint and more compact design. ... ... 14, 2009 -- ThermoFab, a US-based thermoforming company, has completed ... Brookfield move from sheet metal to a plastic enclosure with ...
(Date:12/11/2009)... -- EntreMed, Inc. (Nasdaq: ENMD ), today ... revenue from sales of Thalomid® during the third ... million. In addition, the Company anticipates a ... fiscal 2009. The difference in estimated and ... reflected in the fourth quarter financial results. ,, ...
Breaking Biology Technology:Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2
... Rankings Include 170 Hospitals and Medical Centers in 16 Specialties, ... 19 Hospitals Included in ... Group today,announced the 2008 publication of America,s Best Hospitals, accessible,today ... July 14., Authoritative and influential, the 2008 America,s Best ...
... SHANGHAI, China, July 11 /Xinhua-PRNewswire/ -- WuXi ... medical device research,and development outsourcing company with ... proudly announced that it has won the ... Class Outsourced R&D in Pharmaceuticals and,Biotechnology., ...
... Molecular Biology Laboratory (EMBL) discovered a new way to make ... method that compares how similar the side effects of different ... the same target molecule. The study, published in Science ... , Similar drugs often share target proteins, modes of action ...
Other Biology Technology:U.S. News Media Group Releases 19th Edition of America's Best Hospitals 2U.S. News Media Group Releases 19th Edition of America's Best Hospitals 3WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology 2WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology 3Teaching old drugs new tricks 2
(Date:12/13/2009)... Yale University researchers has used nanosensors to measure ... time. Their findings, which appear December 13 in ... , could dramatically simplify the way physicians test ... , The teamled by Mark Reed, Yale,s ... and Tarek Fahmy, an associate professor of biomedical ...
(Date:12/11/2009)... "green" trend, educators worldwide are relying more ... science knowledge. Studies have revealed that bringing ... just science scoresenvironmental-based lessons can also improve ... Naturally, educators are interested in developing new ... the classroom in hopes of piquing student ...
(Date:12/11/2009)... plants photosynthesize, absorb carbon dioxide and produce oxygen, ... photosynthesis has had on Earth. One of those ... of photosynthesis is Jeffrey Touchman, assistant professor in ... Oxygen, one of the by-products of photosynthesis by ... algae and higher plants), transformed the Precambrian Earth ...
Breaking Biology News(10 mins):Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Students learn environmental stewardship, improve science scores 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Communities Nationwide Learn Less Is More from Metabolife 28R 29 Through 1 000 In Home Parties and An Interactive Site www joinlessismore com 59003 1Communities Nationwide Learn Less Is More from Metabolife 28R 29 Through 1 000 In Home Parties and An Interactive Site www joinlessismore com 59003 2Communities Nationwide Learn Less Is More from Metabolife 28R 29 Through 1 000 In Home Parties and An Interactive Site www joinlessismore com 59003 3Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinsons Disease 59000 1Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinsons Disease 59000 2Botsford Hospital Cancer Center Earns Silver LEED Certification from the U S Green Building Council 58997 1Botsford Hospital Cancer Center Earns Silver LEED Certification from the U S Green Building Council 58997 2Botsford Hospital Cancer Center Earns Silver LEED Certification from the U S Green Building Council 58997 3
... Today,s opening of a new breast health center ... provide significant research opportunities for the Translational Genomics Research ... Center will include a tumor biorepository for TGen that ... ways to diagnose and treat breast cancer, which affects ...
... come in a variety of sizes and shapes, making ... Tomato Analyzer is "rapidly becoming the standard for fruit ... Talbot Brewer of The Ohio State University,s Department of ... Tomato Analyzer research were published in a recent issue ...
... industry has been growing rapidly since the mid-1980s, ... annually. Examples of nontimber forest products (NTFP) include ... herbal products, and specialty floral and decorative products. ... used to satisfy increasing consumer demand for herbal ...
Other Biology News:Breast health center gives TGen new research opportunities 2New and improved tomato analyzer 2Decreasing deer damage 2Decreasing deer damage 3
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
WTAP Antibody...
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
... polyclonal to MSY2/YBOX2 ( Abpromise ... Antigen: Synthetic peptide derived ... C-terminus of Human MSY2/YBOX2. (Note: ... (Peptide available as ...
Biology Products: